NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Reliance Industries to Announce Q4 Results on April 24, 2026

Reliance Industries, the oil-to-telecom conglomerate led by Mukesh Ambani, is set to announce its Q4 results on Friday, April 24, 2026. The meeting of the Board of Directors is scheduled to consider and approve the standalone and consolidated audited financial results for the quarter and year ended March 31, 2026. The RIL board will also recommend a dividend on equity shares for FY26.

Ahead of the Q4 results, Reliance Industries' share price was trading marginally lower, following a 15% crash in 2026 so far. Despite this, the company's financial performance for the fourth quarter of FY26 is expected to show subdued earnings primarily due to continued weakness in its oil-to-chemicals (O2C) segment and modest growth in the retail business.

Reliance Jio, the telecom arm of the company, is expected to deliver strong earnings growth, which will contrast with the subdued performance of the O2C segment. On a consolidated basis, the company's Q4FY26 revenue is projected to rise 9% quarter-on-quarter to ₹2,88,746 crore, up from ₹2,64,905 crore in the previous quarter.

Read also: SpaceX Seeks Record $75 Billion IPO, Potentially Positioning Elon Musk as the World's First Trillionaire

QuarterRevenue (₹ crore)Net Profit (₹ crore)
Q3FY262,64,90518,645
Q4FY262,88,74619,390

Net profit is estimated to increase by 4% to ₹19,390 crore, compared to ₹18,645 crore in Q3FY26. Consolidated EBITDA is expected to remain largely flat, in the range of ₹45,000 crore to ₹46,000 crore. However, EBITDA margins are likely to see a sharp contraction, mainly due to pressure in the O2C business.

Investor Takeaway

Reliance Industries' Q4 results may show subdued earnings due to weakness in its O2C segment.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.